PARKINSON'S-DISEASE

PARKINSON'S-DISEASE

Millennium Management LLC Acquires 128,743 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)

Introduction In a significant move in the pharmaceutical industry, Millennium Management LLC has increased its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) by a staggering 395.1% during the second quarter. This acquisition reflects a growing interest in the company's innovative treatments and potential for future growth..

PARKINSON'S-DISEASE

Comprehensive data for studying serum exosome microRNA transcriptome in Parkinson’s disease patients

Parkinson’s disease (PD), the second most prevalent neurodegenerative disorder, has long been attributed to alphasynuclein aggregation and the subsequent loss of dopaminergic neurons in the substantia..

PARKINSON'S-DISEASE

Cell X Technologies and Aspen Neuroscience collaborate to address throughput and scalability in manufacturing automation to facilitate iPSC cell processing.

A Breakthrough in Parkinson's Disease Treatment In a groundbreaking move, Cell X Technologies and Aspen Neuroscience have announced a collaborative effort aimed at enhancing the efficiency and scalability of iPSC (Induced Pluripotent Stem Cell) cell processing..